Saving Lives with Human Data - Swiss Re313bc47c-8338-4c8b-8061-c349db… · Saving Lives with Human...
Transcript of Saving Lives with Human Data - Swiss Re313bc47c-8338-4c8b-8061-c349db… · Saving Lives with Human...
Confidential - Please do not Distribute1
Saving Lives with Human Data
Confidential - Please do not Distribute
2
Proven At Scale In HealthcareCustomers: HealthcareTrack Record & Team
Millions of devices delivered to OEM partners.
Shipped High Volume Scale to United Healthcare & Pfizer
Screening & Validation Programs
Team: Proven Execution across Striiv & Centrality
CardiacWorks Out of the Box
Depression &Mental Health Smoking
Confidential - Please do not Distribute
3
Deep Technical & Product Experience
A
2010: Founded SmartAccel, Barometer, TouchScreen
2011
PlayBluetooth, Barometer
2013
BandJournaling, Touch Screen
2014
Fusion & BioTouch Screen, Heart Rate
2015
Bio2 & Fusion 2Cont. PPG
2016
Apex HRApnea, Afib, Mental Health
2017
Apex HR Vapor
2018
Sweat Vapor
Confidential - Please do not Distribute
5
Striiv Platform Solution
Biometric Data• Detection of Arrhythmia (AFIB, SVT, etc..)• Assessment of mental health
• Depression & Anxiety• Measurement of heart rate variability, resting heart rate, sleep
Authentication• User continuity can be assured via several data points:
• Gait analysis, heart beat morphology• IoT proximities, voice validation• Video Authentication via App or Website.
Lifestyle Data• Activity• Sleep• Driving/Transport
Striiv’s core solution focuses on data capture and modeling to quantify many aspects of the member.
AFIB/Cardiac
Sleep
Depression
ActivityIdentity
Smoking
DNA HIV, Drugs
Confidential - Please do not Distribute
Clinical Wearables/Sensor Landscape
6
Validation & Screening Opportunity at Scale: This is a greenfield opportunity, where Striiv can secure a leadership role in validation and screening and connect data across multiple sensors & signals.
Consumer, Sports, Fashion
FDA Medical /Diagnostics
Cos
ts &
Use
r Fric
tion
High Friction
Low Friction
Validation & & Screening
Blood TestsBiopsy
Investigator & Doctor Visits
App and Web User Data Entry
Urine Test
Confidential - Please do not Distribute7
Customer Program Examples
Confidential - Please do not Distribute
8
STORY… (Pain, , Scale, Stroke,
Data Driven Insurance & Personalized Deductibles
Default Device
Confidential - Please do not Distribute
9
STORY… (Pain, , Scale, Stroke,
Pilot Validation: Pfizer sells more Lyrica if it bundled a Pfizer wearable that gave patients a digital therapy to manage pain & anxiety. It is superior in upfront prescriptions, and monthly renewals vs. baseline incentive programs.
Customer Pain: Pfizer required control of User Experience, Custom Data (Authentication), and Device Distribution.
Striiv’s Value: Deliver objective/subjective measures and UX requirements.
New Commercial Programs: Pfizer has scaled from Lyrica to kick off two additional drug franchises. (Arthritis and Hemophilia) Customized Data, and SDK integrations. Eliquis is pending Afib Free Wearable
Confidential - Please do not Distribute
Pfizer’s BeLive Project
UNDERSTAND BETTERTO LIVE BETTER
PROGRAM BENEFITSFOR PATIENTS
Customized Wearables & Data Services
Jeff KeislingPfizer CIO
“BeLive results show that 78% of patients who use the device are more likely to follow their doctor’s advice to stick with the plan.”
“In a pilot in Brazil, 76% of health care providers said BeLive enabled them to do more for their patients suffering from pain.”
Confidential - Please do not Distribute12
Member Engagement Inforce Claims ReductionArrhythmia (AFIB) Assessment
Confidential - Please do not Distribute
Program Benefits1.Member Benefits:
- Insight & Coaching on Activity, Sleep Quality, Heart Health, and Stress- Early Risk Assessment to Avoid Stroke or Heart Failure
2.Payer Benefits:- Champion of the Member: Wellness, Prevention & Early Intervention- Reduction in Claims: Cardiac, Stroke & Dementia has significant impact in hospital stays, long term care, and Co-Morbidities. - High Resolution Biometric & Behavioral Data to model and predict claims for future risk stratification .
Confidential - Please do not Distribute
14
In healthy people, the atrium beats between 60-80bpm, for those with afib, the atrium flutters at a rate above 300bpm
What is Atrial fibrillation?
65+Age Hypertension
Who is at risk?
TreatmentAnti-coagulants and blood thinners are Up to 80% Effective
What if you could find and treat AF before they file claims related to dementia and stroke?
Why AFIB MattersPeople with AF are33% more likelyto develop dementia
More than 70% of people with AF will die from a stroke.
plaque and blood clots in the heart
blood clots travel to the brain and cause strokes
Reduced blood flow to the brain attributes to dementia
Confidential - Please do not Distribute
Atrial Fibrillation Profoundly Impacts Life Insurance
15
+500%Stroke Chance
+250%Heart Attack Chance
Non-Presenting During Cardiologist
Visit
32 MillionHigh Risk in US
65yrs+ Hypertension
$25K+ LossLong Term Care,
Surgery, Co-Morbidities
+33%Dementia
Confidential - Please do not Distribute
16
Arrythmia Risk Assessment
#1 #2 #3 #4
✓FDA 510K Cleared ECG Monitor
Risk of Arrhythmia
Confidential - Please do not Distribute
The Flow
17
1 2 3Push the “on” Button
Wear up to 10 DaysSelf-Addressed Paid :) Drop it in a Mailbox
Receive Results Member is Diagnosed& Treated
4
Entire Program is $40-$50 for Life Insurance Validate Meds & SurgeryVia Database Pull. (MHR, PH, APS)
Confidential - Please do not Distribute
Simple Issue+ Underwriting in a Box1.Member Benefits:
- Better Coverage or Premium options- Avoid Paramedical Exam
2.Payer Benefits:- Close the Protection Gap with a simple self-Service Kit.- Validate Smoking, HIV, Substance Abuse, Cardiac, Driving patterns, Sleep, Activity,Stress, and other Applicant data (DNA).
PRO
Confidential - Please do not Distribute
Saliva + Wearable
Identity Cardiac SmokingDrugs Driving Activity
Sleep Depression DNA
Basic Copyright Notice & Disclaimer
©2017 This presentation is copyright protected. All rights reserved. You may download or print out a hard copy for your private or internal use. You are not permitted to create any modifications or derivatives of this presentation without the prior written permission of the copyright owner.
This presentation is for information purposes only and contains non-binding indications. Any opinions or views expressed are of the author and do not necessarily represent those of Swiss Re. Swiss Re makes no warranties or representations as to the accuracy, comprehensiveness, timeliness or suitability of this presentation for a particular purpose. Anyone shall at its own risk interpret and employ this presentation without relying on it in isolation. In no event will Swiss Re be liable for any loss or damages of any kind, including any direct, indirect or consequential damages, arising out of or in connection with the use of this presentation.